Literature DB >> 33388494

Generalized anxiety and depressive symptoms in various age groups during the COVID-19 lockdown in Poland. Specific predictors and differences in symptoms severity.

Małgorzata Gambin1, Marcin Sękowski2, Małgorzata Woźniak-Prus2, Anna Wnuk3, Tomasz Oleksy4, Andrzej Cudo5, Karolina Hansen4, Mirosława Huflejt-Łukasik4, Karolina Kubicka4, Agnieszka Ewa Łyś4, Joanna Gorgol4, Paweł Holas4, Grażyna Kmita4, Emilia Łojek4, Dominika Maison4.   

Abstract

BACKGROUND: Previous studies carried out in different countries have indicated that young adults experienced higher levels of emotional distress, in the form of depressive and anxiety symptoms, than older age groups during the COVID-19 pandemic. However, little is known about which pandemic-related difficulties and factors may contribute to these forms of emotional distress in various age groups.
PURPOSE: The aim of the current study was to investigate: (i) differences in levels of depressive and generalized anxiety symptoms in four age groups in the Polish population during the COVID-19 lockdown; (ii) differences in perceived difficulties related to the pandemic in these groups; and (iii) which factors and difficulties related to the pandemic are the best predictors of generalized anxiety and depressive symptoms in various age groups during the COVID-19 lockdown.
METHOD: A total of 1115 participants (aged 18-85) took part in the study. The sample was representative of the Polish population in terms of sex, age, and place of residence. Participants completed the following online: the Patient Health Questionnaire-9, the Generalized Anxiety Disorder-7, a Scale of Perceived Health and Life Risk of COVID-19, a Social Support Scale, and a Scale of Pandemic-Related Difficulties.
RESULTS: Younger age groups (18-29 and 30-44) experienced higher levels of depressive and generalized anxiety symptoms than older adults (45-59 and 60-85 years). Household relationship difficulties were among the most significant predictors of depressive and generalized anxiety symptoms in all age groups. Fear and uncertainty related to the spread of the virus was one of the most important predictors of emotional distress in all the groups apart from the adults between 18 and 29 years, whereas difficulties related to external restrictions were one of the most significant predictors of depressive and anxiety symptoms exclusively in the youngest group.
CONCLUSIONS: The youngest adults and those experiencing difficulties in relationships among household members are the most vulnerable to depressive and generalized anxiety symptoms during the COVID-19 lockdown. It is important to plan preventive and therapeutic interventions to support these at-risk individuals in dealing with the various challenges related to the COVID-19 pandemic.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  COVID-19 lockdown; Coronavirus; Depressive symptoms; Generalized anxiety symptoms; Pandemic

Year:  2020        PMID: 33388494     DOI: 10.1016/j.comppsych.2020.152222

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  25 in total

1.  Life Satisfaction and Perceived Stress versus Health Promoting Behavior among Medical Students during the COVID-19 Pandemic.

Authors:  Karina Badura-Brzoza; Paweł Dębski; Patryk Główczyński; Małgorzata Dębska-Janus; Piotr Gorczyca
Journal:  Int J Environ Res Public Health       Date:  2022-05-31       Impact factor: 4.614

2.  Generalized anxiety disorder among mothers attending perinatal services during COVID-19 pandemic: using ordinal logistic regression model.

Authors:  Mesfin Esayas Lelisho; Amanuel Mengistu Merera; Seid Ali Tareke; Sali Suleman Hassen; Sebwedin Surur Jemal; Admasu Markos Kontuab; Meseret Mesfin Bambo
Journal:  Heliyon       Date:  2022-06-22

3.  The Association Between Men's Mental Health During COVID-19 and Deterioration in Economic Status.

Authors:  Dorit Hadar-Shoval; Michal Alon-Tirosh; Kfir Asraf; Lubna Tannous-Haddad; Orna Tzischinsky
Journal:  Am J Mens Health       Date:  2022 Mar-Apr

4.  Investigation of psychiatric symptoms in individuals in Turkey during the COVID-19 outbreak.

Authors:  Hülya Kök Eren
Journal:  Perspect Psychiatr Care       Date:  2021-04-24       Impact factor: 2.223

5.  COVID-19-Related Concerns and Symptoms of Anxiety: Does Concern Play a Role in Predicting Severity and Risk?

Authors:  Tarek Benzouak; Sasha Gunpat; Esther L Briner; Jennifer Thake; Steve Kisely; Sanjay Rao
Journal:  Cureus       Date:  2021-11-29

6.  More Depressive Symptoms, Alcohol and Drug Consumption: Increase in Mental Health Symptoms Among University Students After One Year of the COVID-19 Pandemic.

Authors:  Ezgi Dogan-Sander; Elisabeth Kohls; Sabrina Baldofski; Christine Rummel-Kluge
Journal:  Front Psychiatry       Date:  2021-12-16       Impact factor: 4.157

7.  Exploring the Frequency of Anxiety and Depression Symptoms in a Brazilian Sample during the COVID-19 Outbreak.

Authors:  Fabiana Silva Ribeiro; Flávia H Santos; Luis Anunciação; Lucas Barrozo; Jesus Landeira-Fernandez; Anja K Leist
Journal:  Int J Environ Res Public Health       Date:  2021-05-01       Impact factor: 3.390

8.  Age, frequency of volunteering, and Present-Hedonistic time perspective predict donating items to people in need, but not money to combat COVID-19 during lock-down.

Authors:  Iwona Nowakowska
Journal:  Curr Psychol       Date:  2021-06-23

9.  Remote learning among students with and without reading difficulties during the initial stages of the COVID-19 pandemic.

Authors:  Joanna Zawadka; Aneta Miękisz; Iwona Nowakowska; Joanna Plewko; Magdalena Kochańska; Ewa Haman
Journal:  Educ Inf Technol (Dordr)       Date:  2021-04-24

10.  COVID-19 Related Fears of Patients Admitted to a Psychiatric Emergency Department during and Post-Lockdown in Switzerland: Preliminary Findings to Look Ahead for Tailored Preventive Mental Health Strategies.

Authors:  Alessandra Costanza; Laura Macheret; Aline Folliet; Andrea Amerio; Andrea Aguglia; Gianluca Serafini; Paco Prada; Guido Bondolfi; François Sarasin; Julia Ambrosetti
Journal:  Medicina (Kaunas)       Date:  2021-12-13       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.